Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Monthly Membership Fee None Coaching & Lifestyle Support None Not offered Nutritional Support None Not offered
usually most pronounced during dose escalation Diarrhea : Affects 12-17% of patients, typically mild to moderate in severity Vomiting : Reported in 6-10% of patients, more common at higher doses Constipation : Occurs in 6-11% of patients Abdominal pain and dyspepsia : Generally transient Decreased appetite : An expected pharmacological effect contributing to weight loss Other documented adverse effects include injection site reactions, hypoglycemia (when used with insulin or sulfonylureas), and less commonly, fatigue
PMID 15713707
L-carnitine: new perspectives on the management of preterm infants [PMID: 40948868] Laboratory literature summary: L-carnitine: new perspectives on the management of preterm infants
Since we begin at a low dose and step it up slowly, side effects are typically mild and settle within the first few weeks
